| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (GC 4543) |
- |
- |
1 － ? |
Piperacillin (Pipracil)  |
209 |
| Staphylococcus aureus (GC 6336 + glycopeptide-intermediate) |
- |
- |
0.03 － ? |
AC98-6446 |
175 |
| Staphylococcus aureus (GIM 1.55) |
- |
- |
0.2 － ? |
Ampicillin (Omnipen) |
1053 |
| Staphylococcus aureus (GIM 1.55) |
- |
- |
100 － ? |
Phyllanthus emblica L. (SFE extract) |
1053 |
| Staphylococcus aureus (GIM 1.55) |
- |
- |
3000 － ? |
Phyllanthus emblica L. (Methanol extract) |
1053 |
| Staphylococcus aureus (Giorgio) |
- |
- |
≤0.008 － ? |
Gemifloxacin |
330 |
| Staphylococcus aureus (Giorgio) |
- |
- |
0.031 － ? |
Des-oximino |
330 |
| Staphylococcus aureus (Giorgio) |
- |
- |
0.13 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
78 |
| Staphylococcus aureus (glycopeptide-intermediate) |
0.03 |
0.06 |
0.015 － 0.06 |
AC98-6446 |
175 |
| Staphylococcus aureus (glycopeptide-intermediate) |
0.25 |
0.5 |
0.06 － 1 |
Tigecycline (GAR-936, Tigacyl) |
16 |
| Staphylococcus aureus (glycopeptide-intermediate) |
1 |
1 |
0.5 － 2 |
Tigecycline (GAR-936, Tigacyl) |
175 |
| Staphylococcus aureus (glycopeptide-intermediate) |
1 |
4 |
0.5 － 16 |
Daptomycin (Cubicin) |
16 |
| Staphylococcus aureus (glycopeptide-intermediate) |
4 |
8 |
0.5 － 16 |
Teicoplanin (Targocid) |
16 |
| Staphylococcus aureus (glycopeptide-intermediate) |
4 |
8 |
1 － 8 |
Teicoplanin (Targocid) |
175 |
| Staphylococcus aureus (glycopeptide-intermediate) |
4 |
8 |
1 － 8 |
Vancomycin (Vancocyn, Lyphocin) |
16 |
| Staphylococcus aureus (glycopeptide-intermediate) |
4 |
8 |
2 － 8 |
Vancomycin (Vancocyn, Lyphocin) |
175 |
| Staphylococcus aureus (glycopeptide-intermediate) |
4 |
16 |
2 － 16 |
Daptomycin (Cubicin) |
16 |
| Staphylococcus aureus (glycopeptide-intermediate) |
>8 |
>8 |
0.25 － >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
175 |
| Staphylococcus aureus (glycopeptide-intermediate) |
>8 |
>8 |
0.25 － >8 |
Levofloxacin (Levaquin, Quixin) |
175 |
| Staphylococcus aureus (glycopeptide-intermediate) |
16 |
32 |
0.25 － 32 |
Levofloxacin (Levaquin, Quixin) |
16 |
| Staphylococcus aureus (glycopeptide-intermediate) |
>32 |
>32 |
0.12 － >32 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
16 |
| Staphylococcus aureus (glycopeptide-intermediate) |
- |
1 |
? － ? |
Quinupristin/Dalfopristin (Synercid) |
1112 |
| Staphylococcus aureus (glycopeptide-intermediate) |
- |
1.5 |
0.06 － 16 |
Dalbavancin |
1112 |
| Staphylococcus aureus (glycopeptide-intermediate) |
- |
1.5 |
? － ? |
Dalbavancin |
1112 |
| Staphylococcus aureus (glycopeptide-intermediate) |
- |
2 |
? － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1112 |
| Staphylococcus aureus (glycopeptide-intermediate) |
- |
8 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
1112 |
| Staphylococcus aureus (glycopeptide-intermediate) |
- |
12 |
? － ? |
Teicoplanin (Targocid) |
1112 |
| Staphylococcus aureus (glycopeptide-intermediate-susceptible) |
- |
- |
0.25 － 2 |
Daptomycin (Cubicin) |
1261 |